BioWorld Science

Jan. 4, 2006

View Archived Issues

Lipid Sciences files IDE for Plasma Delipidation System-2

Read More

Private placement funds to support phase II Reolysin development

Read More

Zydus Cadila files IND for antiinflammatory compound ZYI-1

Read More

Samaritan initiates new phase IIb for SP-01A in HIV

Read More

Positive results from synDNA hepatitis B study

Read More

InSite Vision completes debt refinancing to support AzaSite development and filing

Read More

Recordati signs agreement with Osmotica for modified-release lercanidipine

Read More

sNDA submission for Seroquel in bipolar depression

Read More

Cerus files IND for phase I study of CRS-100

Read More

New designer antibacterial agents from Rib-X Pharmaceuticals

Read More

MBX-037 demonstrates antibacterial potential of DNA polymerase IIIC inhibitors

Read More

New agents with activity against HIV reported in patent literature

Read More

New agents and strategies for respiratory disorders

Read More

Cervical cancer vaccine induces greater response in younger women

Read More

Inhaled aztreonam reduces P. aeruginosa in cystic fibrosis patients

Read More

NDA submission for telbivudine in chronic hepatitis B

Read More

U.S. launch for Increlex

Read More

Symadex studied in metastatic breast cancer

Read More

KRX-0401 studied in new phase II trial for multiple myeloma

Read More

Selective targeting of the immunoproteasome for hematologic malignancies

Read More

Nonapprovable letter for Cesamet labeling changes

Read More

AZD-2479 for dyslipidemia begins phase I study

Read More

Studies reveal antibiotic activity of CSA-13

Read More